← SearchPHASE I RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY TO ASSESS SAFETY, TOLERABILITY, AND PHARMACOKINETICS$305,772N01FY2024NSNIHPpd Development Lp, Wilmington NCInvestigatorsStephen PeroutkacontactView original record on NIH RePORTER →